Sanofi-Aventis Agrees To Cap Insulin Costs At $35 In Minn. Settlement Agreement

( September 16, 2024, 2:09 PM EDT) -- NEWARK, N.J. — A New Jersey federal judge signed off on an agreement to dismiss with prejudice all claims levied by Minnesota against Sanofi-Aventis U.S. LLC after the company agreed to make its insulin XE "insulin"  products available to consumers in Minnesota for no more than $35 for a monthly subscription....